Clinical Trial Update: A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate single ascending doses of PATAS trifluoroacetate in healthy volunteers; recruitment is ongoing, with Type 2 Diabetes listed as the con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PATAS Trifluoroacetate (PATAS trifluoroacetate)

Snippet

Sponsor: AdipoPharma LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: RECRUITING